» Articles » PMID: 12566387

Constitutive Knockout of Surf1 is Associated with High Embryonic Lethality, Mitochondrial Disease and Cytochrome C Oxidase Deficiency in Mice

Overview
Journal Hum Mol Genet
Date 2003 Feb 5
PMID 12566387
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

We report here the creation of a constitutive knockout mouse for SURF1, a gene encoding one of the assembly proteins involved in the formation of cytochrome c oxidase (COX). Loss-of-function mutations of SURF1 cause Leigh syndrome associated with an isolated and generalized COX deficiency in humans. The murine phenotype is characterized by the following hallmarks: (1) high post-implantation embryonic lethality, affecting approximately 90% of the Surf1(-/-) individuals; (2) early-onset mortality of post-natal individuals; (3) highly significant deficit in muscle strength and motor performance; (4) profound and isolated defect of COX activity in skeletal muscle and liver, and, to a lesser extent, heart and brain; (5) morphological abnormalities of skeletal muscle, characterized by reduced histochemical reaction to COX and mitochondrial proliferation; (6) no obvious abnormalities in brain morphology, reflecting the virtual absence of overt neurological symptoms. These results indicate a function for murine Surf1 protein (Surf1p) specifically related to COX and recapitulate, at least in part, the human phenotype. This is the first mammalian model for a nuclear disease gene of a human mitochondrial disorder. Our model constitutes a useful tool to investigate the function of Surf1p, help understand the pathogenesis of Surf1p deficiency in vivo, and evaluate the efficacy of treatment.

Citing Articles

Multiomics of Aging and Aging-Related Diseases.

Kiseleva O, Arzumanian V, Ikhalaynen Y, Kurbatov I, Kryukova P, Poverennaya E Int J Mol Sci. 2025; 25(24.

PMID: 39769433 PMC: 11677528. DOI: 10.3390/ijms252413671.


Disease models of Leigh syndrome: From yeast to organoids.

Henke M, Prigione A, Schuelke M J Inherit Metab Dis. 2024; 47(6):1292-1321.

PMID: 39385390 PMC: 11586605. DOI: 10.1002/jimd.12804.


Fetal and obstetrics manifestations of mitochondrial diseases.

Adelizzi A, Giri A, Di Donfrancesco A, Boito S, Prigione A, Bottani E J Transl Med. 2024; 22(1):853.

PMID: 39313811 PMC: 11421203. DOI: 10.1186/s12967-024-05633-6.


Animal Models of Mitochondrial Diseases Associated with Nuclear Gene Mutations.

Averina O, Kuznetsova S, Permyakov O, Sergiev P Acta Naturae. 2024; 15(4):4-22.

PMID: 38234606 PMC: 10790356. DOI: 10.32607/actanaturae.25442.


Identification of TMEM126A as OXA1L-interacting protein reveals cotranslational quality control in mitochondria.

Poerschke S, Oeljeklaus S, Cruz-Zaragoza L, Schenzielorz A, Dahal D, Hillen H Mol Cell. 2024; 84(2):345-358.e5.

PMID: 38199007 PMC: 10805001. DOI: 10.1016/j.molcel.2023.12.013.